• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2005 Fiscal Year Final Research Report Summary

Role of the phosphatidylserine receptor in development of hematopoietic cells

Research Project

Project/Area Number 16390144
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Immunology
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

FUKUI Yoshinori  These findings reveals the molecular mechanisms of functional and pathological angiogenesis in various human diseases, and suggest the possible molecular targets both of angiogenic and antiangiogenic therapies., Medical Institute of Bioregulation, Professor, 生体防御医学研究所, 教授 (60243961)

Project Period (FY) 2004 – 2005
Keywordsphosphatidylserine receptor / apoptotic cells / phagocytosis / anemima / T cell development
Research Abstract

Clearance of apoptotic cells by macrophages is considered important for prevention of inflammatory responses leading to tissue damage. The phosphatidylserine receptor (PSR) has been identified as a molecule expressed on macrophages, fibroblasts and epithelial cells, which specifically binds to PS exposed on apoptotic cells. However, several molecules have been also implicated in the recognition and ingestion of apoptotic cells by macrophages. These include cell-surface molecules such as CD14,class A scavenger receptor, ATP binding cassette transporter 1,receptor tyrosine kinase Ax1/Mer/Tyro3,and α_Vβ_3 integrin which, in association with CD36,binds to thrombospondin recognized by an undefined ligand on apoptotic cells. In addition, two soluble molecules, growth arrest-specific gene 6 product and milk fat globule-EGF-factor 8,have been reported to bind to PS. Therefore, although in vitro experiments clearly indicate that PSR is involved in anti-inflammatory clearance of cells undergoing apoptosis, the physiological relevance of PSR remains unclear. To address this issue, we generated PSR-deficient mice by homologous recombination in embryonic stem (ES) cells. PSR^<-/-> mice exhibited severe anemia and died during the perinatal period. In the PSR^<-/-> fetal livers, erythroid differentiation was blocked at an early erythroblast stage. In addition, PSR^<-/-> embryos exhibited thymus atrophy owing to a developmental defect of T-lymphoid cells. Clearance of apoptotic cells by macrophages was impaired in both liver and thymus of PSR^<-/-> embryos. However, this did not induce up-regulation of inflammatory cytokines. These results indicate that during embryonic development, PSR is required for definitive erythropoiesis and T-lymphopoiesis, independently of the prevention of inflammatory responses.

  • Research Products

    (12 results)

All 2006 2005 2004

All Journal Article (12 results)

  • [Journal Article] DOCK2 is required in T cell precursors for development of Vα14 natural killar T (NKT) cells2006

    • Author(s)
      Kunisaki Y. et al.
    • Journal Title

      J. Immunol. (in press)

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] DOCK2 is required in T cell precursors for development of Vα14 natural killar T (NKT) cells2006

    • Author(s)
      Kunisaki Y. et al.
    • Journal Title

      J.Immunol. (in press)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection.2005

    • Author(s)
      Jiang H. et al.
    • Journal Title

      J. Exp. Med. 22

      Pages: 1121-1130

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] リンパ球の運動性を制御する分子DOCK22005

    • Author(s)
      福井 宣規
    • Journal Title

      医学のあゆみ 213

      Pages: 2915-2920

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Deletion of DOCK2,a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection.2005

    • Author(s)
      Jiang H. et al.
    • Journal Title

      J.Exp.Med. 22

      Pages: 1121-1130

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] DOCK2 is a molecule that determines lymphocyte motility2005

    • Author(s)
      Fukui Y.
    • Journal Title

      Igaku no ayumi 213

      Pages: 2915-2920

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Defective fetal liver erythropoiesis and T-lymphopoiesis in mice lacking phosphatidylserine receptor2004

    • Author(s)
      Kunisaki Y. et al.
    • Journal Title

      Blood 103

      Pages: 3362-3364

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Differential requirements for DOCK2 and phoshoinositide-3-kinase γ during T and B lymphocyte homing2004

    • Author(s)
      Nombela-Arrieta C. et al.
    • Journal Title

      Immunity 21

      Pages: 429-441

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] 免疫シナプス形成を制御するCDMファミリー分子DOCK22004

    • Author(s)
      福井 宣規
    • Journal Title

      Molecular Medicine 増刊「免疫2005」 41

      Pages: 75-83

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] MHCによる免疫システムの構築2004

    • Author(s)
      福井 宣規
    • Journal Title

      ゲノム医学 4

      Pages: 331-336

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] DOCK2 is crifical for immunological synapse formation2004

    • Author(s)
      Fukui Y.
    • Journal Title

      Molecular Medicine Zoukan 'Men-eki2005' 41

      Pages: 75-83

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] MHC-mediated immune system organaization2004

    • Author(s)
      Fukui Y.
    • Journal Title

      Genomu igaku 4

      Pages: 331-336

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2007-12-13  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi